Understanding and Using Isothermal Gene Assembly for Synthetic Biology
News Aug 28, 2012
Integrated DNA Technologies (IDT) provides a unique insight into the fundamentals of isothermal synthetic gene assembly in this quarter’s edition of the company’s Decoded newsletter.
The technique, which was pioneered in 2009 by Daniel Gibson and colleagues at The J. Craig Venter Institute in Maryland, USA, allows several overlapping DNA fragments to be combined in a single reaction.
In this way, large synthetic DNA molecules many hundreds of kilobases long can be generated using a minimal number of enzymatic steps.
This limits potential errors due to repeated handling of samples and reagents, while simplifying the process by avoiding the need for multiple experimental setups.
The article in the latest issue of Decoded outlines the theory behind isothermal assembly, and provides advice for designing and creating synthetic gene constructs using the method.
Users can read more about the latest genomic trends, tips and research in the most recent issue of IDT’s quarterly newsletter, Decoded.
IDT has also released its new gBlock Gene Fragments, which simplify, speed up and reduce the cost of creating large, custom DNA constructs.
Single-stranded Origami Technology Drives Drug Delivery Systems and Pharmaceutical Nanofactories ForwardNews
First nanotechnological approach enables the design and replication of complex single-stranded DNA and RNA origami with potential for drug delivery and nanofabrication.READ MORE
Cracking the Code of Coenzyme Q BiosynthesisNews
Coenzyme Q is a vital cog in the body’s energy-producing machinery, a kind of chemical gateway in the conversion of food into cellular fuel. Researchers are developing new tools to shed light on CoQ function, primarily by finding and defining proteins that have a direct link to the chemical. This includes the development of a new multi-omic strategy to identify the global function of an RNA-binding protein that has long been associated with mitochondria and its role in CoQ biosynthesis.READ MORE
First Successful Gene Therapy Trial Reported for People with Hemophilia ANews
Patients with hemophilia A who received a single infusion of an investigational gene therapy showed improved levels of the essential blood clotting protein FVIII, with 11 of 13 achieving normal or near-normal FVIII levels.READ MORE